Cite
HARVARD Citation
Chu, M. et al. (2017). Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy. Journal of cachexia, sarcopenia and muscle. 8 (2), pp. 298-304. [Online].